CBD company Chanelle McCoy Health has received approval to start a trial which may allow it to sell its CBD sleeping aid as an over-the-counter (OTC) drug in Australian pharmacies.
The British brand has received ethics approval to begin the third and last phase of an efficacy clinical trial before its synthetic CBD formulation can be marketed in Australia as a non-prescription treatment for sleeping difficulties No CBD product has so far received authorisation to be sold as an OTC medicine in pharmacies in Australia.
...
Need help?
Contact a sales representative right now and don’t wait
“ Aussie approval puts Chanelle McCoy on the way toward OTC sleeping aid sales ”
Buy report request information:
“ Aussie approval puts Chanelle McCoy on the way toward OTC sleeping aid sales ”
CBD company Chanelle McCoy Health has received approval to start a trial which may allow it to sell its CBD sleeping aid as an over-the-counter (OTC) drug in Australian pharmacies.
The British brand has received ethics approval to begin the third and last phase of an efficacy clinical trial before its synthetic CBD formulation can be marketed in Australia as a non-prescription treatment for sleeping difficulties No CBD product has so far received authorisation to be sold as an OTC medicine in pharmacies in Australia.
Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
LATEST ALERTS
